Skip to main content

Peer Review reports

From: SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy

Original Submission
1 Dec 2022 Submitted Original manuscript
3 Jan 2023 Reviewed Reviewer Report
13 Apr 2023 Reviewed Reviewer Report
2 May 2023 Author responded Author comments - Chuanben Chen
Resubmission - Version 2
2 May 2023 Submitted Manuscript version 2
Publishing
5 May 2023 Editorially accepted
21 Jul 2023 Article published 10.1186/s12885-023-10920-4

You can find further information about peer review here.

Back to article page